Viva Biotech Holdings (VB0) — Strategic Asset Allocation Index
Viva Biotech Holdings (VB0) has a Strategic Asset Allocation Index of 52.6% as of June 2023. Strategic assets (PP&E of €1.91 Billion plus long-term investments of €-) total €1.91 Billion, measured against net assets of €3.64 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how resilient are Viva Biotech Holdings's assets to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Viva Biotech Holdings Strategic Asset Allocation Index (2016–2021)
This chart shows how Viva Biotech Holdings's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of June 2023, the index stands at 52.6%, representing strategic assets of €1.91 Billion against net assets of €3.64 Billion EUR. See Viva Biotech Holdings free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Viva Biotech Holdings (2016–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Viva Biotech Holdings from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see VB0 market cap overview.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 44.1% | €1.72 Billion | €1.72 Billion | €- | €3.91 Billion | ▲ +24.4 pp |
| 2020 | 19.6% | €737.01 Million | €737.01 Million | €- | €3.76 Billion | ▲ +10.8 pp |
| 2019 | 8.8% | €156.99 Million | €156.99 Million | €- | €1.78 Billion | ▼ -17.8 pp |
| 2018 | 26.6% | €66.90 Million | €66.90 Million | €- | €251.44 Million | ▲ +4.1 pp |
| 2017 | 22.5% | €34.40 Million | €34.40 Million | €- | €152.76 Million | ▼ -5.4 pp |
| 2016 | 27.9% | €21.34 Million | €21.34 Million | €- | €76.50 Million | — |